Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide as additive to cardioplegia in cardiac surgery
NCT04830982Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Sep 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of diazoxide in Myocardial stunning, sponsored by Johns Hopkins University. Primary endpoint: Mean Arterial Blood Pressure at 24 hours. Planned start Sep 2023; status: withdrawn.
02
Drugs
diazoxide
03
Conditions
Myocardial stunning
Beyond the preview
Go deeper on NCT04830982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04830982.